Profil
Stephen M Hahn is currently the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
He is also a Director at Ion Beam Applications SA and Faeth Therapeutics, Inc., both positions starting in 2026.
Additionally, Mr. Hahn holds the position of Head-Executive Clinical & Regulatory at Turn Therapeutics, Inc. Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Aktive Positionen von Stephen Hahn
| Unternehmen | Position | Beginn |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Direktor/Vorstandsmitglied | 16.06.2026 |
| FAETH THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.06.2026 |
| TURN THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Vorstandsvorsitzender | 20.08.2025 |
Ausbildung von Stephen Hahn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Global Health Solutions Inc
Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
















